Cell and gene therapy media and reagents: the breakdown

Written by Megan Giboney
CAR-T Cell therapy Clinical manufacturing Gene therapy GMP Opinion Stem cells

The success of cell and gene therapies depends heavily on the quality and consistency of the materials used during their development and manufacturing. Among these materials, media and reagents play a critical role in ensuring the viability, growth and functionality of cells.

Here, we break down the differences between several types of media and reagents and explore the advantages of each.

Serum free

Serum-free media are formulations that do not contain animal serum, such as fetal bovine serum, which has traditionally been used as a supplement in cell culture. Serum-free media are designed to provide all the necessary nutrients, growth factors and hormones required for cell growth and maintenance without the variability associated with serum.

Advantages:

  • Reduced variability: Serum-free media reduces the batch-to-batch inconsistencies inherent in serum, leading to more reproducible results.
  • Improved safety: The absence of serum reduces the risk of contamination with adventitious agents, such as viruses or prions.
  • Regulatory compliance: Serum-free media are more aligned with Good Manufacturing Practices and regulatory requirements for clinical-grade cell and gene therapies.

Serum-free media are widely used in the expansion of T cells, mesenchymal stem cells and other cell types critical to cell and gene therapy applications.

Chemically defined

Chemically defined media are formulations in which all components are known and characterized at the molecular level. These media do not contain any undefined or complex mixtures, such as serum or hydrolysates.

Advantages:

  • High reproducibility: The defined composition ensures consistent performance across experiments and manufacturing batches.
  • Enhanced control: Researchers and manufacturers can precisely control the cellular environment, optimizing conditions for specific cell types or processes.
  • Regulatory clarity: The transparency of chemically defined media simplifies regulatory approval processes by eliminating unknown variables.

Chemically defined media are particularly valuable in the production of viral vectors, such as lentiviruses and adeno-associated viruses for gene therapy.

Defined formulation

Defined formulation media are similar to chemically defined media but may include components that are not fully characterized at the molecular level, such as plant hydrolysates or yeast extracts. These media strike a balance between performance and cost-effectiveness.

Advantages:

  • Cost efficiency: Defined formulation media are often more affordable than fully chemically defined media while still offering improved consistency compared to serum-containing media.

Defined formulation media are commonly used in upstream bioprocessing for cell and gene therapy manufacturing, particularly in early-stage development.

Animal component free

Animal component-free (ACF) media are formulations that do not contain any components derived from animal sources. This includes both direct ingredients (e.g., serum) and indirect components (e.g., enzymes used in processing).

Advantages:

  • Ethical considerations: ACF media align with ethical concerns regarding the use of animal-derived materials.
  • Reduced contamination risk: The absence of animal components minimizes the risk of introducing animal-derived pathogens.
  • Regulatory compliance: ACF media are often required for therapies intended for human use, as they meet stringent regulatory standards.

ACF media are widely used in the expansion of stem cells and immune cells, as well as in the production of viral vectors.

Xeno free

Xeno-free media are a subset of animal component-free media that exclude materials derived from non-human animals. However, they may include human-derived components, such as human serum albumin or human platelet lysate.

Advantages:

  • Human compatibility: Xeno-free media reduce the risk of immune reactions or rejection when cells are transplanted into patients.
  • Regulatory alignment: These media meet the requirements for clinical-grade cell therapies, particularly in jurisdictions with strict xeno-free mandates.

Xeno-free media are commonly used in the development of both autologous and allogeneic cell therapies, where compatibility with the human immune system is critical.

Protein free

Protein-free media are formulations that do not contain any proteins, whether animal- or human-derived. These media rely on small molecules, peptides and other non-protein components to support cell growth and function.

Advantages:

  • Reduced immunogenicity: The absence of proteins minimizes the risk of immune responses in therapeutic applications.
  • Simplified downstream processing: Protein-free media reduce the complexity of purification processes, particularly in the production of viral vectors or exosomes.
  • Enhanced stability: Protein-free formulations are often more stable, with longer shelf lives and reduced risk of degradation.

Protein-free media are increasingly used in the production of exosomes.

This content is part of the RegMedNet Spotlight on raw materials and supply chain. Click here to view the full feature and discover expert insights on this topic >>>